Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28050908 | 0.97 | ELANE (0.36) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| Water SCHEMBL27280881 | 0.97 | ELANE (0.36) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| SCHEMBL1984289 | 0.95 | ELANE (0.35) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| SCHEMBL7860268 | 0.89 | ELANE (0.38) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| Dioxane SCHEMBL27712549 | 0.87 | SMN1; SMN2 (0.53) | ELANEDGAT1USP2SMN1; SMN2ALDH1A1 | |
| SCHEMBL19946006 | 0.86 | ELANE (0.36) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| SCHEMBL8375577 | 0.85 | DGAT1 (0.42) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| SCHEMBL5452 | 0.85 | DGAT1 (0.42) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| Acetic Acid SCHEMBL28157839 | 0.83 | FFAR3 (0.39) | ELANEDGAT1USP2SMN1; SMN2HDAC6 | |
| SCHEMBL29740062 | 0.82 | DGAT1 (0.40) | ELANEDGAT1USP2SMN1; SMN2HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4096 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594306-A1 | SYNTHESIS METHODS AND INTERMEDIATES FOR THE PRODUCTION OF REMIBRUTINIB | Novartis AG (CH) | 2025-08-06 | — | — | EP | claimed |
| CN-119998265-A | Synthetic methods and intermediates for the production of rebaudinib | 诺华股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119707895-A | Preparation method of 7-formyl-2, 3-dihydrobenzofuran-4-carbonitrile | 江苏苏中药业研究院有限公司 | 2025-03-28 | — | — | CN | claimed |
| WO-2025054244-A1 | CELLULAR DATA LIBRARY AND METHODS OF USING THE SAME | CELLARITY, INC. (US) | 2025-03-13 | — | — | WO | claimed |
| CN-119490652-A | High-resilience PA6 polyamide thermoplastic elastomer, and preparation method and application thereof | 东华大学 | 2025-02-21 | — | — | CN | claimed |
| WO-2024069507-A1 | SYNTHESIS METHODS AND INTERMEDIATES FOR THE PRODUCTION OF REMIBRUTINIB | NOVARTIS AG (CH) | 2024-04-04 | — | — | WO | claimed |
| WO-2024024935-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE HAVING ANTINEOPLASTIC EFFECT | 第一三共株式会社 | 2024-02-01 | — | — | WO | claimed |
| CN-117396479-A | Method for preparing carbanucleoside using amide | 吉利德科学公司 | 2024-01-12 | — | — | CN | claimed |
| WO-2024011067-A2 | METHODS OF MANUFACTURE OF R-MDMA | Mind Medicine, Inc. (US) | 2024-01-11 | — | — | WO | claimed |
| CN-117120444-A | Method for preparing carbanucleoside using amide | 吉利德科学公司 | 2023-11-24 | — | — | CN | claimed |
| US-20040247880-A1 | NANOPOROUS LAMINATES | BLUE CUBE IP LLC | 2004-12-09 | — | — | US | claimed |
| WO-2004026814-A2 | PROCESS FOR THE SYNTHESIS OF INTERMEDIATES USEFUL FOR THE SYNTHESIS OF TUBULIN INHIBITORS | WYETH HOLDINGS CORPORATION (US) | 2004-04-01 | — | — | WO | claimed |
| US-20040063904-A1 | Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors | WYETH HOLDINGS CORPORATION | 2004-04-01 | — | — | US | claimed |
| WO-2002004417-A1 | PROCESS FOR THE PREPARATION OF DERIVATIVES OF 4-AMINO-3-HYDROXYPYRROLE-2-CARBOXYLIC ACID | PHARMACIA CORPORAION (US) | 2002-01-17 | — | — | WO | claimed |
| EP-0944603-A1 | PROCESS FOR MAKING 2-AMINO-2-IMIDAZOLINE, GUANIDINE, AND 2-AMINO-3,4,5,6-TETRAHYDROPYRIMIDINE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-29 | — | — | EP | claimed |
| WO-1998023595-A1 | PROCESS FOR MAKING 2-AMINO-2-IMIDAZOLINE, GUANIDINE, AND 2-AMINO-3,4,5,6-TETRAHYDROPYRIMIDINE DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | claimed |
| US-5510522-A | AMIDATION, IODINATION, METALLIZATION, RADIOFLUORINATION OF DOPA AND DERIVATIVES THEREOF; SHELF STABLE PRECURSOR, HIGH YIELDS | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-04-23 | — | — | US | claimed |
| WO-1994000460-A9 | SYNTHESIS OF N-FORMYL-3,4-DI-t-BUTOXYCARBONYLOXY-6-(TRIMETHYLSTANNYL)-L-PHENYLALANINE ETHYL ESTER AND ITS REGIOSELECTIVE RADIOFLUORODESTANNYLATION TO 6-[18F]FLUORO-L-DOPA | — | 1994-02-17 | — | — | WO | claimed |
| WO-1994000460-A1 | SYNTHESIS OF N-FORMYL-3,4-DI-t-BUTOXYCARBONYLOXY-6-(TRIMETHYLSTANNYL)-L-PHENYLALANINE ETHYL ESTER AND ITS REGIOSELECTIVE RADIOFLUORODESTANNYLATION TO 6-[18F]FLUORO-L-DOPA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-01-06 | — | — | WO | claimed |
| EP-0457250-A2 | Novel bifunctional linking compounds, conjugates and methods for their production | BRISTOL-MYERS SQUIBB COMPANY (US) | 1991-11-21 | — | — | EP | claimed |